We are live on ! Find out more
DRTS icon

Alpha Tau Medical
DRTS

18 hedge funds and large institutions have $4.01M invested in Alpha Tau Medical in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

29% more funds holding

Funds holding: 14 → 18 (+4)

0.06% more ownership

Funds ownership: 0.95% → 1.02% (+0.06%)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

32% less capital invested

Capital invested by funds: $5.92M → $4.01M (-$1.91M)

Holders
18
Holders Change
+4
Holders Change %
+28.57%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
3
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$294K
2
Citigroup
Citigroup
New York
+$262K
3
WANY
Wealthspire Advisors (New York)
New York
+$200K
4
Renaissance Technologies
Renaissance Technologies
New York
+$168K
5
Wells Fargo
Wells Fargo
California
+$95.3K

Top Sellers

Rank Fund Capital Flow
1
PF
Phoenix Financial
Israel
-$335K
2
E
Ergoteles
New York
-$273K
3
HSBC Holdings
HSBC Holdings
United Kingdom
-$148K
4
Barclays
Barclays
United Kingdom
-$144K
5
Morgan Stanley
Morgan Stanley
New York
-$61.1K

DRTS Hedge Fund Activity: Q3 2022 in Review

18 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Alpha Tau Medical (DRTS) for Q3 2022, worth a combined $4.01M — down 32% from $5.92M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new DRTS positions and 5 closed out — a net gain of 4 holders — while 3 added to existing stakes and 4 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $294K. The largest seller was Phoenix Financial, cutting an estimated $335K.

  • 18 institutional investors held Alpha Tau Medical (DRTS) as of Q3 2022, up from 14 in Q2 2022.
  • Funds reported $4.01M of Alpha Tau Medical stock for Q3 2022, down 32% quarter-over-quarter.
  • 9 funds opened new Alpha Tau Medical positions in Q3 2022 and 5 closed out, a net change of +4 holders.
  • The largest Alpha Tau Medical buyer in Q3 2022 was Fidelity Investments, an estimated $294K added.
  • The largest Alpha Tau Medical seller in Q3 2022 was Phoenix Financial, an estimated $335K sold.

Based on aggregated 13F filings for Q3 2022.